Recon: J&J says second shot boosts protection against moderate to severe COVID; AZ to invest $360M in Irish manufacturing site
ReconMichael MezherBiologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy